New approaches: The present chemotherapeutic approach and those monoclonals targeting growth factors have not made a major impact on survival. The specific immunogenic protein characterizing colorectal cancer has been isolated, defined and can be used as a vaccine. The effect is production of an IgG1 that targets the tumor. IgG1 given IV works in 6-8hrs. if needed for advanced cases, vaccine for prevention P.O
Answered 6/20/2014
4k views
3 doctors weighed in across 3 answers
5 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question